|
Indian Journal of Medical Sciences
Medknow Publications on behalf of Indian Journal of Medical Sciences Trust
ISSN: 0019-5359 EISSN: 1998-3654
Vol. 59, Num. 4, 2005, pp. 163-164
|
Indian Journal of Medical Sciences, Vol. 59, No. 4, April, 2005, pp. 163-164
Letter To Editor
Olanzapine-induced double incontinence
Sagar R., Varghese S.T., Balhara Y.P.S.
Department of Psychiatry, All India Institute of Medical
Sciences, New Delhi
Correspondence Address: Department of Psychiatry, All India Institute
of Medical Sciences, New Delhi - 110029, India. E-mail: sunny_tv@rediffmail.com
Code Number: ms05025
Sir,
Urinary and faecal incontinence induced by olanzapine.
Olanzapine, a newer antipsychotic, is among the commonly prescribed
antipsychotics around the world. The side effect profile of these newer
antipsychotics
is better than that of the typical antipsychotic medication. There is
only one case report of fecal incontinence[1] and
one report of urinary incontinence with olanzapine.[2] We
would like to report a patient having urinary and fecal incontinence
on olanzapine.
A 35-year-old man was admitted for the treatment of an episode of mania.
His serum lithium level was 2.94 mEq/L for which he underwent hemodialysis
twice after that his serum lithium level was 0.44 mEq/L. His signs and
symptoms of lithium toxicity resolved in next few days. The patient was
started with 20 mg/day of olanzapine to control the symptoms of mania.
Patient did not have any residual deficit due to lithium toxicity and
had full control of his bowel and bladder before the treatment was initiated.
In a few days, he complained of bowel and bladder incontinence. Routine
urine screening and stool examinations were within normal limits. The
neurological examination was normal at the time and his serum lithium
was 0.02 mEq/L. The double incontinence persisted despite the addition
of an anticholinergic (trihexyphenydyl hydrochloride). Keeping the possibility
of a drug-induced phenomenon, the olanzapine dose was reduced to 10 mg/day,
and the incontinence resolved within few days. The patient was started
on sodium valproate and olanzapine was stopped later. The patient is
asymptomatic at the time of reporting this case.
The adverse drug reaction probability score[3] for
the patient was nine denoting a definite adverse reaction due to olanzapine.
Incontinence, reported with clozapine[4] and
risperidone, is uncommon with olanzapine. Two cases of incontinence have
been reported in patients taking olanzapine.[1,2] One
report suggests the response of urinary incontinence with ephedrine.[2] An
overall numerical increase in the incidence of urinary incontinence with
olanzapine as compared to placebo has been reported among patients with
Alzheimer's disease.[5] The
pathophysiology of this phenomenon is likely to be due to the action on
central micturition pathways than the peripheral action. A study on anesthetized
rats showed the inhibitory effects of olanzapine on the external urethral
sphincter.[6] Although the antimuscarinic
side effect would predict urinary retention, incontinence is due to its
central mechanism.[6] The physician
should be aware of this rare side effect of olanzapine.
References
1. | Mendhekar DN, Srivastav PK, Sarin SK, Jiloha RC. A case report of olanzapine-induced fecal incontinence. J Clin Psychiatry 2003;64:339. Back to cited text no. 1 [PUBMED] [FULLTEXT] |
2. | Vernon LT, Fuller MA, Hattab H, Varnes KM. Olanzapine-induced urinary incontinence: Treatment with ephedrine. J Clin Psychiatry 2000;61:601-2. Back to cited text no. 2 [PUBMED] |
3. | Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. Back to cited text no. 3 [PUBMED] |
4. | Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine induced urinary incontinence: Incidence and treatment with ephedrine. J Clin Psychiatry 1996;57:514-8. Back to cited text no. 4 [PUBMED] |
5. | De Deyn PP, Carrasco MM, Deberdt W, Jeandel C, Hay DP, Feldman PD, et al. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2004;19:115-26. Back to cited text no. 5 [PUBMED] [FULLTEXT] |
6. | Vera PL, Miranda-Sousa A, Nadelhaft I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BM Cent Pharmacol 2001;1:4. Back to cited text no. 6 [PUBMED] [FULLTEXT] |
Copyright 2005 - Indian Journal of Medical Sciences
|